Publication in refereed journal
香港中文大学研究人员 ( 现职)
| 周喜林教授 (药剂学院) |
全文
| 没有全文档案提供 |
引用次数
Scopushttp://aims.cuhk.edu.hk/converis/portal/Publication/1Scopus source URL
其它资讯
摘要Although scientific evaluations for product bioavailability performance have been routinely employed in most European and North American countries, debate continues on the potential problems of bioavailability and bioequivalency of pharmaceutical products in Hong Kong. Data obtained from these evaluations not only confirm the quality of the drug products in the market, but also permit a more rational selection of pharmaceutical products to achieve cost-effectiveness. It is well known that chemical equivalency may not necessarily imply bioequivalency due to the interplay of various formulation, pathophysiological and physicochemical factors. This paper discusses some of the basic concepts and implications of these evaluations.
着者Li R.C., Chow A.H.L., Yip M.S., Raymond K.
期刊名称Hong Kong Medical Journal
出版年份http://aims.cuhk.edu.hk/converis/portal/Publication/1995
月份http://aims.cuhk.edu.hk/converis/portal/Publication/12
日期http://aims.cuhk.edu.hk/converis/portal/Publication/1
卷号http://aims.cuhk.edu.hk/converis/portal/Publication/1
期次http://aims.cuhk.edu.hk/converis/portal/Publication/1
出版社Hong Kong Academy of Medicine Press
出版地Hong Kong
页次63 - 68
国际标準期刊号http://aims.cuhk.edu.hk/converis/portal/Publication/1024-2708
电子国际标準期刊号2226-8707
语言英式英语
关键词bioavailability, bioequivalency, definitions, pharmacokinetic parameters
